Seven Bridges Advisors LLC Buys 67 Shares of athenahealth, Inc. (NASDAQ:ATHN)
Seven Bridges Advisors LLC increased its stake in shares of athenahealth, Inc. (NASDAQ:ATHN) by 5.4% during the second quarter, Holdings Channel reports. The institutional investor owned 1,303 shares of the health services provider’s stock after buying an additional 67 shares during the period. Seven Bridges Advisors LLC’s holdings in athenahealth were worth $183,000 as of its most recent SEC filing.
A number of other hedge funds also recently added to or reduced their stakes in the stock. FNY Partners Fund LP raised its stake in athenahealth by 1,900.0% in the first quarter. FNY Partners Fund LP now owns 1,000 shares of the health services provider’s stock valued at $112,000 after buying an additional 950 shares in the last quarter. Russell Investments Group Ltd. bought a new stake in athenahealth during the fourth quarter valued at about $118,000. Bessemer Group Inc. raised its stake in athenahealth by 13.7% in the second quarter. Bessemer Group Inc. now owns 938 shares of the health services provider’s stock valued at $132,000 after buying an additional 113 shares in the last quarter. Teza Capital Management LLC bought a new stake in athenahealth during the first quarter valued at about $220,000. Finally, World Asset Management Inc bought a new stake in athenahealth during the second quarter valued at about $253,000.
Shares of athenahealth, Inc. (NASDAQ:ATHN) opened at 142.01 on Wednesday. athenahealth, Inc. has a 12 month low of $90.11 and a 12 month high of $158.66. The firm’s 50-day moving average price is $143.35 and its 200-day moving average price is $124.81. The stock has a market capitalization of $5.67 billion, a P/E ratio of 180.22 and a beta of 1.77.
athenahealth (NASDAQ:ATHN) last issued its earnings results on Thursday, July 20th. The health services provider reported $0.51 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.39 by $0.12. The business had revenue of $301.10 million for the quarter, compared to analysts’ expectations of $298.68 million. athenahealth had a return on equity of 6.91% and a net margin of 2.80%. The business’s revenue for the quarter was up 15.0% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.34 EPS. On average, equities research analysts forecast that athenahealth, Inc. will post $1.91 EPS for the current year.
Several analysts have issued reports on the company. UBS AG reissued a “buy” rating and set a $152.00 price target (up previously from $123.00) on shares of athenahealth in a report on Wednesday, May 31st. Citigroup Inc. reaffirmed a “buy” rating and issued a $163.00 price objective (up previously from $128.00) on shares of athenahealth in a research note on Monday, June 5th. Piper Jaffray Companies reaffirmed a “buy” rating and issued a $152.00 price objective on shares of athenahealth in a research note on Friday, July 14th. Oppenheimer Holdings, Inc. upped their price objective on athenahealth from $154.00 to $184.00 and gave the stock an “outperform” rating in a research note on Friday, July 21st. Finally, Wells Fargo & Company reaffirmed an “outperform” rating and issued a $190.00 price objective (up previously from $130.00) on shares of athenahealth in a research note on Saturday, July 22nd. Three research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and thirteen have assigned a buy rating to the stock. athenahealth currently has a consensus rating of “Hold” and an average target price of $148.64.
In other news, SVP Jonathan D. Porter sold 300 shares of the business’s stock in a transaction that occurred on Monday, May 15th. The stock was sold at an average price of $109.48, for a total transaction of $32,844.00. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Brandon H. Hull sold 800 shares of the business’s stock in a transaction that occurred on Monday, July 3rd. The stock was sold at an average price of $140.81, for a total value of $112,648.00. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 22,905 shares of company stock worth $3,120,107. Insiders own 3.20% of the company’s stock.
athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.
Want to see what other hedge funds are holding ATHN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for athenahealth, Inc. (NASDAQ:ATHN).
Receive News & Ratings for athenahealth Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth Inc. and related companies with MarketBeat.com's FREE daily email newsletter.